Hospitals, health systems and clinics at ObesityWeek 2026
Nov 14–17, 2026 National Harbor, MD ~4.4k attendees Website
135 hospitals, health systems and clinics are at ObesityWeek 2026 — 300 presentations on the program and 4 with a booth in the exhibit hall. Most represented: Mayo Clinic (19 on the program), Cleveland Clinic (9 on the program), Brigham and Women's Hospital (7 on the program). 48 of them have their own page in this guide. As of Nov 12, 2026.
Topic
Top represented
Showing 1–3 of 135 organizations
| Organization | ObesityWeek 2026 Attendance |
|---|---|
Mayo Clinic Rochester, MN | |
Nonprofit academic medical center based in Rochester, Minnesota, with campuses in Arizona and Florida. | Talk Sat Nov 14 1:45pm–2:00pm Session Sat Nov 14 4:30pm–5:30pm Talk Sat Nov 14 4:30pm–4:45pm Talk Sun Nov 15 9:00am–9:15am Session Sun Nov 15 10:30am–11:30am Talk Sun Nov 15 10:30am–11:15am Why One Size Will Never Fit All: Biological Diversity in Obesity and Treatment Response Explores why people respond so differently to anti-obesity drugs and metabolic surgery, and how biological variation could guide more personalized obesity care. Neuroscience of appetite and eatingInterventional and clinical studiesClinical obesity care and professional practiceBariatric surgery and devices Poster Sun Nov 15 2:30pm–3:30pm Aleniglipron in Participants Living with Overweight or Obesity: ACCESS Trial Open-Label Extension Obesity pharmacotherapy and drug developmentInterventional and clinical studies Poster Sun Nov 15 2:30pm–3:30pm Weight History and Eating Behaviors in Adults Undergoing Bariatric Surgery Obesity pharmacotherapy and drug developmentClinical obesity care and professional practice Poster Sun Nov 15 2:30pm–3:30pm Women's Experiences with GLP-1 Receptor Agonists: Qualitative Insights from the WISH Study Clinical obesity care and professional practice Poster Sun Nov 15 2:30pm–3:30pm Early Treatment Response and Gene Risk Score for Satiation Stratify Weight Loss Trajectories for GLP-1 Receptor Agonists Clinical obesity care and professional practicePopulation health and epidemiology Poster Sun Nov 15 2:30pm–3:30pm Baseline Predictors of Semaglutide and Tirzepatide Induced Nausea and Vomiting: A Real-World Multivariable Analysis Metabolism and integrative physiology Poster Sun Nov 15 2:30pm–3:30pm Weight Maintenance After Side Effects-Prompted GLP-1 Treatment De-escalation in Adults With Obesity Obesity pharmacotherapy and drug developmentClinical obesity care and professional practice Poster Sun Nov 15 2:30pm–3:30pm Adipose Tissue Inflammation After Weight Loss Through Bariatric Surgery and Lifestyle Intervention Interventional and clinical studiesObesity pharmacotherapy and drug development Poster Sun Nov 15 2:30pm–3:30pm A Machine Learning-Derived Gene Risk Score and Semaglutide Response in Adolescents With Obesity Obesity pharmacotherapy and drug developmentClinical obesity care and professional practice Poster Sun Nov 15 2:30pm–3:30pm Semaglutide Discontinuation in Adolescents With Obesity: Real World Patterns and Subsequent Therapy Obesity pharmacotherapy and drug developmentClinical obesity care and professional practice Poster Sun Nov 15 2:30pm–3:30pm What Patients Want: Are Weight-Loss Goals Realistic Relative to the Strategies Patients Are Willing to Adopt? Interventional and clinical studies Session Sun Nov 15 3:30pm–4:30pm Talk Sun Nov 15 5:10pm–5:20pm A Machine Learning-Derived Gene Risk Score and Semaglutide Response in Adolescents With Obesity Metabolism and integrative physiologyObesity pharmacotherapy and drug developmentPediatric and adolescent obesityBariatric surgery and devicesNutrition, diet and foodInterventional and clinical studies Talk Mon Nov 16 10:15am–10:30am Talk Mon Nov 16 10:25am–10:30am Graded Cardiometabolic Benefits Across Weight-Loss Response With GLP-1-Based Therapies Metabolism and integrative physiologyNeuroscience of appetite and eatingInterventional and clinical studiesPopulation health and epidemiologyPolicy and public health Poster Mon Nov 16 2:30pm–3:30pm Diet Quality and Fat Deposition: Ultra-Processed Food Intake Beyond Energy Intake Population health and epidemiology Poster Mon Nov 16 2:30pm–3:30pm Graded Cardiometabolic Benefits Across Weight-Loss Response With GLP-1–Based Therapies Chronic disease and obesity complications Talk Mon Nov 16 4:00pm–4:15pm Talk Mon Nov 16 5:30pm–5:50pm Stigma-related Trauma and Obesity Care Complexity Clinical obesity care and professional practiceBariatric surgery and devicesNutrition, diet and food Talk Mon Nov 16 5:50pm–6:10pm Integrating Trauma Screening Into Obesity Treatment Pathways Clinical obesity care and professional practiceBariatric surgery and devicesNutrition, diet and food Talk Mon Nov 16 6:00pm–6:15pm Talk Tue Nov 17 8:40am–9:00am When Food Stops Working: Clinical Care After MBS and Incretin Therapy Clinical obesity care and professional practice Talk Tue Nov 17 8:45am–9:00am |
Cleveland Clinic Cleveland, OH | |
Academic health system in Cleveland uniting patient care, research and education; it exhibits to recruit physicians. | Booth Exhibiting at Booth 738 Sat, Nov 147pm–9:30pmSun, Nov 159:30am–4pmMon, Nov 169:30am–4pm Talk Sat Nov 14 4:30pm–4:45pm What’s New in Bariatric Surgery - And Why It Matters Clinically Clinical obesity care and professional practiceBariatric surgery and devicesObesity pharmacotherapy and drug development Talk Sat Nov 14 4:45pm–5:00pm Talk Sat Nov 14 5:00pm–5:15pm Poster Sat Nov 14 7:30pm–8:30pm Weight Trajectories in Type 2 Diabetes: Glucose-Lowering Therapy and Clinical Outcomes Neuroscience of appetite and eatingObesity pharmacotherapy and drug development Poster Sun Nov 15 2:30pm–3:30pm Clinician Perceptions of Semaglutide and Tirzepatide & Alternative Therapies Considered for Obesity Clinical obesity care and professional practice Poster Sun Nov 15 2:30pm–3:30pm Asymmetric Re-Titration After Discontinuation of GLP-1 and GLP-1/GIP Receptor Agonists: Dose Patterns Differ Between Obesity and Type 2 Diabetes Clinical obesity care and professional practice Session Mon Nov 16 8:30am–9:30am TOS/ASMBS Joint Symposium: Horizons in Collaborative Obesity Treatment Experts survey new obesity treatments, from next-generation drugs to combined approaches, and how medical and surgical teams can work together. Clinical obesity care and professional practiceObesity pharmacotherapy and drug developmentBariatric surgery and devices Talk Mon Nov 16 8:45am–9:00am Published and Real World Evidence of Anti-Obesity Medications and Metabolic and Bariatric Surgery Clinical obesity care and professional practiceObesity pharmacotherapy and drug developmentBariatric surgery and devices Session Mon Nov 16 12:00pm–1:00pm TOS Clinical Practice Section Meeting (TOS members only) - Obesity Medicine in 2031: What Will It Look Like? A multidisciplinary panel looks ahead to obesity care in 2031, then the section recognizes its clinician and practitioner awards for obesity care. Clinical obesity care and professional practice Session Mon Nov 16 5:00pm–6:30pm The Hidden Burden of Trauma in Obesity: What Health Care Professionals Need to Know Explains how trauma can shape weight, treatment engagement and outcomes, and offers trauma-informed ways to build trust and reduce stigma in care. Clinical obesity care and professional practiceBariatric surgery and devicesNutrition, diet and food |
Brigham and Women's Hospital Boston, MA | |
Harvard-affiliated teaching hospital in Boston, part of Mass General Brigham. | Talk Sat Nov 14 11:55am–12:10pm Changing the Treatment Paradigm in Overweight and Obesity Management Interventional and clinical studiesPopulation health and epidemiologyClinical obesity care and professional practiceMetabolism and integrative physiologyObesity pharmacotherapy and drug development Talk Sat Nov 14 12:10pm–12:35pm Beyond The Scale: The Clinical Relevance of Body Composition, Body Fat Distribution and Lean Mass Interventional and clinical studiesPopulation health and epidemiologyClinical obesity care and professional practiceMetabolism and integrative physiologyObesity pharmacotherapy and drug development Talk Sat Nov 14 1:00pm–1:10pm The Next Frontier: How May New Therapies for Overweight and Obesity Impact Body Composition? Interventional and clinical studiesPopulation health and epidemiologyClinical obesity care and professional practiceMetabolism and integrative physiologyObesity pharmacotherapy and drug development Poster Sat Nov 14 7:30pm–8:30pm Elecoglipron Improves Beta-Cell Function and Insulin Resistance in Adults With Type 2 Diabetes Chronic disease and obesity complicationsObesity pharmacotherapy and drug development Session Sun Nov 15 10:30am–11:30am TOS/KSSO Collaborative Symposium: Unpacking Adipose Tissue - From Basic Biology to Precision Obesity Interventions Covers fat tissue as an active organ, comparing white, brown and beige fat, and links its biology to precision obesity care using biomarkers. Metabolism and integrative physiology Poster Sun Nov 15 2:30pm–3:30pm Rationale and Design of the KaiNETIC-1 and -2 Trials of Ribupatide in People Living With Obesity Obesity pharmacotherapy and drug developmentInterventional and clinical studies Poster Sun Nov 15 2:30pm–3:30pm Novel and off-Label Uses of GLP-1 Receptor Agonists: A Systematized Narrative Review Interventional and clinical studies Poster Sun Nov 15 2:30pm–3:30pm Inpatient Protein-Sparing Modified Fast With/Without Sleeve Gastrectomy in Acute Respiratory Failure Bariatric surgery and devices Poster Sun Nov 15 2:30pm–3:30pm Self-Reported Dosing Behaviors Among US Adults Using GLP-1 RAs for Weight Loss: A Survey Study Obesity pharmacotherapy and drug developmentInterventional and clinical studies Poster Mon Nov 16 2:30pm–3:30pm Associations Between Magnitude of Weight Reduction and Healthcare Resource Utilization Population health and epidemiology Poster Mon Nov 16 2:30pm–3:30pm Representativeness of Five Landmark GLP-1 Receptor Agonist Trials: An NHANES-Based Comparison Policy and public health Poster Mon Nov 16 2:30pm–3:30pm |
Find buyers from hospitals, health systems and clinics
Tell us what you sell and we’ll find the people at these hospitals, health systems and clinics most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Browse ObesityWeek 2026 by
Organization type
Topic
- Obesity pharmacotherapy and drug development 251
- Clinical obesity care and professional practice 196
- Interventional and clinical studies 231
- Metabolism and integrative physiology 217
- Nutrition, diet and food 164
- Pediatric and adolescent obesity 117
- Population health and epidemiology 156
- Chronic disease and obesity complications 224
- Neuroscience of appetite and eating 97
- Bariatric surgery and devices 58
- Policy and public health 102
Exhibit hall
Everyone
Not affiliated with or endorsed by The Obesity Society (TOS), ObesityWeek® or the American Society for Metabolic and Bariatric Surgery (ASMBS). Submit a correction